The skeleton in many diseases is osteopenic. Osteogenesis imperfecta is such a one. There are no grounds for believing that by driving mineral into the bone, even if that were possible, any deficiency in bone mass would be altered. Unless, that is, one believes that by so doing net bone formation would result, adding to the skeletal mass. Perhaps in the paper in question this is what is intended to be conveyed by 'remineralizing the skeleton'. However, nowhere is this stated, and one is left with the very strong impression that movement of mineral into and out of the skeleton independently of any modulation of tissue mass is at stake. The hypothesis could be that the treatment causes osteoid to mineralize, thereby inducing more to be formed, by an amount in excess of that concurrently being removed by the resorption phase of the turnover process. If it is this hypothesis that was being tested then it has not stood up to the experimental observations. Yours faithfully PAUL D BYERS I December 1980 several times too small; so, for example, the function and connections of the nerve fibres cut in the operation of pre-frontal leucotomy are only vaguely understood.
We could practise psychiatry a bit better if we only had elementary knowledge of how the brain works. Not only is there a dearth of good psychiatric researchers, there is an even greater dearth of workers in the basic anatomical and physiological sciences, who are less well paid than their clinical colleagues.
There is a cheering prospect in the future from the results of genetic engineering. We now have the ability to isolate human genes and their products so that they can be investigated pharmacologically. This is an enormous short cut in medical scienceand it is difficult to overestimate its possibilities. There are 30000 genes in man, and the investigation of this number of potent pharmacological agents would daunt the largest manufacturer. Nevertheless, it can be done, and it is likely that the next ten years of medical science might be more productive than the last two thousand. (November 1980 Journal, p 780) , or is the which must include the brain should be an integral difficulty only semantic? The question arises from part of current and future studies of dementia so their use of the words demineralization, that there is more sense in this field. mineralization, and remineralization.
In the Mortality Statistics for England and Emphasis on the duality of the tissues making Wales for 1978 (Table 2, Series DH2, No.5, 1978) up the skeleton, i.e. bone and osteoid, is helpful in death is recorded as due to 'senile dementia' talking about bone disease. Observations on bone (290.0) in 1093 women and 380 men (three in the and mineral concentration have yet to show age group 55-59 and the rest older), and 'presenile variation from normal in health or disease, dementia' (290.1) in 78 women and 62 men (25 in excepting focal areas of perilacunar mineral the age groups from 40-59 and the rest older). deficiency in the osteomalacias, which are Senile and presenile dementia together are by far insufficient to affect the appearance of clinical the largest subgroup in the category of 'psychoses' radiographs. What does vary is the proportion of' (290-299). Some probably similar cases are listed bone and osteoid, and the total skeletal mass they. under 'senility and ill defined diseases' (790-796): constitute. Thus we can think of osteomalacia as a the category of 'senility without mention of reduced amount of bone, most obvious in the later psychosis' (794) includes 1160 women and 279 stages, clothed in an excess of osteoid (a state men (all older than 64 years). It is currently arrived at by successive cycles of bone resorption assumed that Alzheimer's disease/senile dementia and its replacement by osteoid which then fails to accounts for a large proportion of cases of be mineralized). Strip away the osteoid and you dementia. The death certification is not regularly have, with respect to bone mass, the equivalent of supported by autopsy and microscopic osteoporosis. This is a skeleton deficient in its examination of the brain. bony component, for which osteopenia is an apt It is likely that some cases under 290 or 794 may description.
belong in other categories, such as 'hypertension'
and 'cerebrovascular disease', with or without hypertension. The death certification system unfortunately does not help in assessing the frequency of dementia in those groups. Clinical, or rarely post-mortem, studies assume that dementia with cerebrovascular disease, brain infarcts or hypertension is relatively rare, accounting for between 10% and 20% of dements. The Mortality Statistics do show many people dying of hypertension seldom with any record of cerebrovascular involvement, and many more of cerebrovascular disease. Hypertension is associated, when haemorrhage and thrombosis are excluded, with cerebrovascular disease in a total of some 4000 cases: (436.0) 'acute but iII defined cerebrovascular disease', 1565 men and 1950 women; (437.0) 'generalised ischaemic cerebrovascular disease', I I7 men and 159 women; and (438.0) 'other and iII defined cerebrovascular disease', 101 men and 138 women.
The above groups, without mention of hypertension, include over 25000 people. The figures quoted are for 1978: there has been a steady rise in the number of cases in these categories over the years. If a proportion of such cases were demented this would somewhat alter the ideas about the incidence of various sorts of dementia. IVAN JANOTA 18 November 1980 Hypokalaemic thyrotoxic periodic paralysis From Professor Robert Volpe Department of Medicine University of Toronto, Ontario. Canada Dear Sir, In his letter on this topic (October 1980 Journal. p 757); Dr C P Petch remarked that 'No one has ever been able to explain ... why this complication of a common disease, so frequent in Japan, is so rare in Western Europe'.
. Surely the matter is one of genetics. Chinese patients with thyrotoxic periodic paralysis are found to have HLA antigens A2-Bw33 and Aw19-B17, and these are not present in patients without thyrotoxic periodic paralysis. On the other hand, in Chinese patients with Graves' disease the common HLA antigen is HLA-Bw46 or Bw46jB40. Thus, it would appear that when particular patients have both sets of antigens, the development of hyperthyroidism would also permit the trait of periodic paralysis to become manifest, whereas it would not become manifest if the hyperthyroidism did not occur. Thus the appearance of thyrotoxic periodic paralysis results from the presence of two coincidental genetic abnormalities which happen to be much more common in the genetic pool of Orientals than in Caucasians (Yeo P P B et al. 1978, British Medical Journal ii, 93(}-932 Medicine' would certainly not cause me to buy it; yet this book is first class and does much to remove the stigma of 'fringe', which the reviewer is at pains to remind us is so often the fate of hypnosis.
Then, again, we read that the chapter on the 'use of hypnosis in the psychiatric field ... might stimulate some psychiatrists to master hypnotic techniques'. When will some hypnotists realize that hypnosis is a therapy, not a technique? Perhaps they feel naked and powerless without their 'techniques'.
Possibly many psychiatrists have mastered the technique and long since gone to 'fresh fields and pastures new'. After all, Freud did . Yours sincerely GORDON AMBROSE 
